ReviewCureus2025
Preserving Function, Enhancing Precision: The Rise of Personalized Endonasal Sinus Surgery.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic rhinosinusitis (CRS) is a common disease with increasing global prevalence that significantly impacts patients' quality of life. Advances in surgical technology and a better understanding of mucosal pathophysiology have transformed its management landscape. However, a notable gap remains in the published literature. This article reviews the evolution of endonasal sinus surgery and presents a position on the emerging concept of "Thinvasive" surgery, a minimally invasive and function-preserving paradigm for the modern management of CRS. A comprehensive review of the historical development, current techniques, and novel approaches in endoscopic sinus surgery was conducted. The transition from traditional external procedures, such as Caldwell-Luc, to functional endoscopic sinus surgery (FESS) marked a pivotal shift toward mucosal preservation and restoration of physiological drainage. Further advancements, such as image-guided FESS, balloon sinuplasty, and other minimal-access modalities, have facilitated more precise and individualized interventions. The Thinvasive approach integrates these innovations with patient-specific assessment strategies, including radiologic and functional evaluation tools like the Sino-Nasal Outcome Test-22, quantum molecular resonance (Telea Medical, Sandrigo, Italy), and Ozilia-kinetic oscillation stimulation (Chordate Medical, Kista, Sweden). The future of endonasal sinus surgery lies in a flexible and personalized continuum. Thinvasive techniques offer a promising hybrid between medical and surgical treatment. Nonetheless, further research is needed to establish their long-term efficacy and to develop standardized patient selection frameworks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.